SKOLNICK PHIL (Chief Scientific Officer) sold 2.6% of their position (627.00 shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/15/2022ACC: 0001385508-22-000111
Officer· Chief Scientific Officer
Since Oct 2018
-627.00
Net shares
Net seller
$7.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
627.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−627.00
Price / share
$11.85
Trade value
$7.43K
% of position
2.6%
7/14/2022
24.45K→23.82K
Total
Net shares
−627.00
Net value
-$7.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2022 | S · Sale | −627.00 | $11.85 | $7.43K | 2.6% | 24.45K | 23.82K |
| Total | −627.00 | -$7.43K | ||||||
Derivative Transactions0
No derivative transactions reported